Silo Pharma, Inc.
SILO
$0.45
$0.000.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 0.00% | |||
| Cost of Revenue | 0.00% | 1,280.00% | |||
| Gross Profit | 0.00% | -116.27% | |||
| SG&A Expenses | -21.03% | 10.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -31.20% | -7.67% | |||
| Operating Income | 31.70% | 7.78% | |||
| Income Before Tax | 20.61% | 7.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 20.61% | 7.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.61% | 7.80% | |||
| EBIT | 31.70% | 7.78% | |||
| EBITDA | 31.77% | 7.83% | |||
| EPS Basic | 44.62% | 37.96% | |||
| Normalized Basic EPS | 44.89% | 38.00% | |||
| EPS Diluted | 44.62% | 37.96% | |||
| Normalized Diluted EPS | 44.89% | 38.00% | |||
| Average Basic Shares Outstanding | 43.38% | 48.59% | |||
| Average Diluted Shares Outstanding | 43.38% | 48.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||